sch 23982 has been researched along with edetic acid in 1 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
---|---|---|---|---|---|
87 | 0 | 0 | 27,553 | 629 | 3,970 |
Protein | Taxonomy | sch 23982 (IC50) | edetic acid (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, K; Sidhu, A | 1 |
1 other study(ies) available for sch 23982 and edetic acid
Article | Year |
---|---|
Ascorbic acid inhibits 125I-SCH 23982 binding but increases the affinity of dopamine for D1 dopamine receptors.
Topics: Animals; Ascorbic Acid; Benzazepines; Cell Membrane; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Edetic Acid; Glutathione; Iodine Radioisotopes; Lipid Peroxidation; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1994 |